Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Sara Loritz Cox, MD, MPH
Internal Medicine · SAINT PAUL, MN · NPI 1073740668
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 711 | 113 |
| Levothyroxine Sodium | Levothyroxine Sodium | 407 | 58 |
| Gabapentin | Gabapentin | 396 | 70 |
| Lisinopril | Lisinopril | 326 | 47 |
| Eliquis | Apixaban | 308 | 53 |
| Pantoprazole Sodium | Pantoprazole Sodium | 305 | 46 |
| Furosemide | Furosemide | 301 | 56 |
| Omeprazole | Omeprazole | 293 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 254 | 55 |
| Amlodipine Besylate | Amlodipine Besylate | 249 | 53 |
| Citalopram Hbr | Citalopram Hydrobromide | 237 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 237 | 36 |
| Sertraline Hcl | Sertraline Hcl | 229 | 37 |
| Trazodone Hcl | Trazodone Hcl | 202 | 31 |
| Losartan Potassium | Losartan Potassium | 178 | 33 |
| Potassium Chloride | Potassium Chloride | 167 | 35 |
| Tamsulosin Hcl | Tamsulosin Hcl | 158 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 156 | 24 |
| Baclofen | Baclofen | 145 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 143 | 21 |
| Metoprolol Tartrate | Metoprolol Tartrate | 143 | 29 |
| Allopurinol | Allopurinol | 138 | 19 |
| Levetiracetam | Levetiracetam | 134 | 19 |
| Mirtazapine | Mirtazapine | 132 | 29 |
| Xarelto | Rivaroxaban | 128 | 15 |
| Carvedilol | Carvedilol | 125 | 25 |
| Simvastatin | Simvastatin | 120 | 18 |
| Latanoprost | Latanoprost | 116 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 112 | 19 |
| Metformin Hcl | Metformin Hcl | 110 | 20 |
| Risperidone | Risperidone | 95 | 14 |
| Memantine Hcl | Memantine Hcl | 93 | 14 |
| Bumetanide | Bumetanide | 91 | 20 |
| Divalproex Sodium | Divalproex Sodium | 88 | 12 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 85 | 15 |
| Spironolactone | Spironolactone | 81 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 80 | 18 |
| Nystatin | Nystatin | 80 | 24 |
| Torsemide | Torsemide | 76 | 13 |
| Jantoven | Warfarin Sodium | 72 | suppressed |
| Jardiance | Empagliflozin | 72 | 11 |
| Metformin Hcl Er | Metformin Hcl | 71 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 70 | 14 |
| Divalproex Sodium Er | Divalproex Sodium | 66 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 63 | 12 |
| Famotidine | Famotidine | 63 | 18 |
| Olanzapine | Olanzapine | 62 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 59 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 57 | 19 |
| Trulicity | Dulaglutide | 55 | suppressed |
| Aripiprazole | Aripiprazole | 53 | suppressed |
| Prednisone | Prednisone | 52 | 18 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 51 | 11 |
| Hydrochlorothiazide | Hydrochlorothiazide | 50 | 11 |
| Insulin Aspart Flexpen | Insulin Aspart | 50 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | 11 |
| Midodrine Hcl | Midodrine Hcl | 47 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 46 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 45 | 27 |
| Myrbetriq | Mirabegron | 43 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 43 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 42 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 42 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 39 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 39 | suppressed |
| Ezetimibe | Ezetimibe | 38 | suppressed |
| Primidone | Primidone | 37 | suppressed |
| Bupropion Xl | Bupropion Hcl | 36 | suppressed |
| Enulose | Lactulose | 36 | suppressed |
| Finasteride | Finasteride | 34 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 33 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 32 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 31 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 31 | suppressed |
| Digoxin | Digoxin | 31 | suppressed |
| Timolol Maleate | Timolol Maleate | 29 | suppressed |
| Carbamazepine Er | Carbamazepine | 28 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Lamotrigine | Lamotrigine | 28 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 27 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 27 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 27 | suppressed |
| Sotalol | Sotalol Hcl | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | suppressed |
| Methocarbamol | Methocarbamol | 26 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 24 | suppressed |
| Ozempic | Semaglutide | 23 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 23 | suppressed |
| Sucralfate | Sucralfate | 23 | suppressed |
| Cyclosporine | Cyclosporine | 22 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 22 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 22 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Calcium Acetate | Calcium Acetate | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 21 | suppressed |
| Loperamide | Loperamide Hcl | 20 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 19 | 12 |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | 14 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 18 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Januvia | Sitagliptin Phosphate | 18 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 18 | suppressed |
| Paliperidone Er | Paliperidone | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 17 | suppressed |
| Difluprednate | Difluprednate | 17 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 17 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | suppressed |
| Lactulose | Lactulose | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 15 | 15 |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 15 | suppressed |
| Nyamyc | Nystatin | 15 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 14 | suppressed |
| Ibuprofen | Ibuprofen | 14 | suppressed |
| Nystop | Nystatin | 14 | suppressed |
| Rhopressa | Netarsudil Mesylate | 14 | suppressed |
| Rivastigmine | Rivastigmine | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | 12 |
| Haloperidol | Haloperidol | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Travoprost | Travoprost | 13 | suppressed |
| Valproic Acid | Valproic Acid | 13 | suppressed |
| Xifaxan | Rifaximin | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Abilify Maintena | Aripiprazole | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Glatopa | Glatiramer Acetate | 11 | suppressed |
| Olanzapine Odt | Olanzapine | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Risperidone Odt | Risperidone | 11 | suppressed |
| Trospium Chloride | Trospium Chloride | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error